IP Library Granted Patent US 8,299,100
Granted Patent B2
US 8,299,100 · App. 12/693,196 · Granted Oct 30, 2012

Potent and selective neuronal nitric oxide synthase inhibitors with improved membrane permeability

Assignee: Northwestern University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,100
App. No.
12/693,196
Granted
Oct 30, 2012
Kind
B2
Abstract

Compounds and related compositions and methods as can be used to inhibit neuronal nitric oxide synthase and can be employed in the treatment of various neurodegenerative diseases, such compounds of a formula

Claims (26)

1. A nitric oxide synthase inhibitor compound of a formula

wherein X is selected from divalent ethylene oxide, cyclopropyl, monofluoroethylene and difluoroethylene moieties; and Φ is selected from phenyl, substituted phenyl, piperidinyl and substituted piperidinyl moieties, or a salt thereof.

2. The compound of claim 1 wherein X is selected from cyclopropyl and difluoroethylene moieties.

3. The compound of claim 2 wherein Φ is selected from phenyl and substituted phenyl moieties.

4. The compound of claim 3 wherein said substituent is selected from halide and alkyl substituents.

5. The compound of claim 4 wherein Φ is m-fluorophenyl.

6. The compound of claim 1 selected from the (S,S) and (R,R) enantiomers.

7. The compound of claim 1 wherein said compound is an ammonium salt.

8. The compound of claim 7 wherein said ammonium salt has a counter ion that is a conjugate base of a protic acid.

9. The compound of claim 1 complexed with a nitric oxide synthase enzyme.

10. A nitric oxide synthase inhibitor compound of a formula

wherein X is selected from divalent ethylene oxide, cyclopropyl, monofluoroethylene and difluoroethylene moieties; and Φ is selected from phenyl, substituted phenyl, piperidinyl and substituted piperidinyl moieties, or a salt thereof wherein the pyridine of said compound is at least partially reduced.

11. The compound of claim 10 complexed with a nitric oxide synthase enzyme.

12. A nitric oxide synthase inhibitor compound of a formula

wherein R is selected from H, halide and alkyl moieties; or a salt thereof.

13. The compound of claim 12 wherein R is halide.

14. The compound of claim 13 wherein R is meta-substituted fluoride.

15. The compound of claim 12 wherein said compound is an ammonium salt.

16. The compound of claim 15 wherein said ammonium salt has a counter ion that is a conjugate base of a protic acid.

17. A method inhibiting a nitric oxide synthase comprising contacting a nitric oxide synthase with an effective amount of a compound of a formula

wherein X is selected from divalent ethylene oxide, cyclopropyl, monofluoroethylene and difluoroethylene moieties; and Φ is selected from phenyl, substituted phenyl, piperidinyl and substituted piperidinyl moieties, or a salt thereof.

18. The method of claim 17 wherein X is selected from cyclopropyl and difluoroethylene moieties.

19. The method of claim 18 wherein Φ is selected from phenyl and substituted phenyl moieties.

20. The method of claim 19 wherein Φ is m-fluorophenyl.

21. The method of claim 17 wherein X is a difluoroethylene moiety and said compound is selected from the (S,S) and (R,R) enantiomers.

22. The method of claim 21 wherein said compound is the (R,R) enantiomer, and said method selective for inhibition of neuronal nitric oxide synthase.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2010
From: SILVERMAN, RICHARD B.; XUE, FENGTIAN
To: NORTHWESTERN UNIVERSITY
Reel/Frame 024042/0085 →
CONFIRMATORY LICENSE Recorded Jan 29, 2010
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023871/0184 →
Continuity (2)
Provisional Application 61205770 · Jan 23, 2009
Related Publication 20100190230A1 · Jul 29, 2010